AG
MGNX icon

Aperio Group’s MacroGenics MGNX Stock Holding History

Aperio Group’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$463K Buy
20,243
+4,268
+27% +$98.3K ﹤0.01% 2002
2020
Q3 		$402K Buy
15,975
+2,139
+15% +$58.4K ﹤0.01% 1935
2020
Q2 		$386K Sell
13,836
-3,198
-19% -$55.5K ﹤0.01% 1897
2020
Q1 		$99K Sell
17,034
-22,327
-57% -$203K ﹤0.01% 2218
2019
Q4 		$428K Buy
39,361
+15,680
+66% +$155K ﹤0.01% 1888
2019
Q3 		$302K Sell
23,681
-4,274
-15% -$61.6K ﹤0.01% 2017
2019
Q2 		$474K Buy
27,955
+12,461
+80% +$214K ﹤0.01% 1808
2019
Q1 		$279K Buy
+15,494
New +$268K ﹤0.01% 2032

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Aperio Group's MGNX Position: Q4 2020 in Review

Aperio Group increased its MacroGenics (MGNX) stake by 27% in Q4 2020, buying an estimated $98.3K and bringing the position to 20,243 shares worth $463K. The position accounts for ﹤0.01% of the portfolio, ranked #2002.

Aperio Group first reported a position in MGNX in Q1 2019 and has held it in 8 quarters since. The position peaked at $474K in Q2 2019. 147 funds tracked by Wall St. Rank hold MGNX as of Q4 2020.

  • Aperio Group held 20,243 shares of MacroGenics worth $463K as of Q4 2020.
  • Aperio Group bought 4,268 MacroGenics shares in Q4 2020, an estimated $98.3K.
  • MacroGenics made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2002 holding.
  • Aperio Group first reported a position in MacroGenics in Q1 2019 and has held it in 8 quarters since.
  • Aperio Group's MacroGenics position peaked at $474K in Q2 2019.
  • 147 funds tracked by Wall St. Rank held MacroGenics as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.